(4-BENZYL-3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)MORPHOLIN-4-YL)METHYL)-5-OXO-1,2,4-TRIAZOL-1-YL)PHOSPHONIC ACID
UNII F85FEZ88HH

Substance Identification & Data

This profile provides standardized clinical and technical data for (4-benzyl-3-(((2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-5-oxo-1,2,4-triazol-1-yl)phosphonic Acid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F85FEZ88HH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2035475-10-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
F85FEZ88HH
CAS Registry Number
2035475-10-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
(4-BENZYL-3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)MORPHOLIN-4-YL)METHYL)-5-OXO-1,2,4-TRIAZOL-1-YL)PHOSPHONIC ACID
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C30H28F7N4O6P
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
NSUPPVQTYMPIQL-BLIZRMSTSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
n1(nc(n(c1=O)Cc2ccccc2)CN3[C@H]([C@H](OCC3)O[C@H](C)c4cc(cc(c4)C(F)(F)F)C(F)(F)F)c5ccc(cc5)F)P(O)(O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for (4-benzyl-3-(((2r,3s)-2-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-5-oxo-1,2,4-triazol-1-yl)phosphonic Acid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(4-BENZYL-3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)MORPHOLIN-4-YL)METHYL)-5-OXO-1,2,4-TRIAZOL-1-YL)PHOSPHONIC ACID